Furthermore, vildagliptin prevents the angiogenesis of high-fat-diet-induced HCC via down-regulating the dipeptidyl peptidase-4/chemokine ligand 2/angiogenesis pathway [42]. Here, DPP4 is linked to hepatocellular carcinoma.